Hook & thesis
Robert Half (RHI) trades at $24.00 and yields roughly 9.8% after the board approved a quarterly dividend of $0.59 per share. That headline yield gets attention for a reason: the company is generating meaningful free cash flow ($266.81M), and at today's market cap of roughly $2.43B the free cash flow yield is on the order of 11% - enough to cover the current dividend run-rate with some cushion.
My thesis is straightforward: buy RHI at or near $24.00 for income and asymmetric upside as the staffing cycle normalizes. The business is cyclical and not without risk, but the combination of cash flow coverage of the dividend, a diversified services mix (Contract Talent Solutions, Permanent Placement, and Protiviti consulting), and early signs of sequential revenue improvement make this an actionable trade with a defined entry, stop and targets.
What Robert Half does and why the market should care
Robert Half is a global staffing and consulting firm. Its segments are: Contract Talent Solutions (accounting, finance, tech, marketing and other contract placements), Permanent Placement Talent Solutions (direct hires for finance and accounting roles), and Protiviti (enterprise consulting in finance, technology, governance, risk and compliance). The mix matters because while staffing is cyclical, Protiviti provides higher-margin, enterprise-driven services that are less volatile and can help steady cash flow during slow hiring cycles.
Investors should care because the stock currently trades at levels that imply the market expects a prolonged downturn in hiring. But two data points argue the downside may already be priced in: (1) shares have fallen to $24.00 from a 52-week high of $51.55 and are only modestly above the 52-week low of $21.83, and (2) recent company commentary and a January earnings print triggered a 26% pop when management pointed to sequential improvements in talent solutions and enterprise revenues.
Key fundamentals and valuation frame
| Metric | Value |
|---|---|
| Current Price | $24.00 |
| Market Cap | $2,427,456,000 |
| EPS (reported) | $1.31 |
| P/E | ~18.25 |
| Dividend (annual) | $2.36 (0.59 qtrly) - yield ~9.8% |
| Free Cash Flow | $266,810,000 |
| EV / EBITDA | 15.29 |
| 52-week Range | $21.83 - $51.55 |
Some quick math that colors valuation: annual dividends equal $2.36 per share, or roughly $238.7M in aggregate per year (2.36 x 101,144,000 shares outstanding). Free cash flow of $266.81M therefore covers the dividend by about 12% (266.81M / 238.70M = ~1.12x). Market cap of $2.43B against FCF of $266.81M implies an FCF yield around 11% - a compelling figure for income-focused investors if cash flow proves stable.
That said, the dividend exceeds reported EPS (annual dividend $2.36 vs EPS $1.31), which pushes the payout ratio above 100% on an earnings basis. The key mitigator is free cash flow coverage rather than GAAP earnings. Investors who prioritize cash-based metrics will view the yield as better supported than the headline payout ratio suggests; investors focused strictly on EPS may rightly be uneasy.
Catalysts that can drive upside
- Continued sequential recovery in hiring: management already cited sequential improvement and a post-earnings pop in late January reflected that commentary. If talent solutions and enterprise revenues keep improving, multiples can re-rate.
- Protiviti momentum: enterprise consulting is stickier and higher margin; steady growth here cushions staffing cyclicality and supports valuation expansion.
- Dividend buyer interest: a near-10% yield attracts income funds and yield-hunting retail investors, providing a stable bid under the stock unless fundamentals deteriorate further.
- Short-covering/back-up squeeze: short interest has increased (23.36M shares as of the 03/13/2026 settlement, ~7.09 days to cover) and heavy short volume in recent sessions can amplify rallies on positive datapoints.
Trade plan - exact actionable levels
- Entry: $24.00 - use limit order or averaged buys between $24.00 and $23.50 if you prefer staggered entry.
- Stop-loss: $21.50 - place a hard stop under the 52-week low and recent support to limit downside.
- Primary target: $40.00 - this is the long-term (180 trading days) target if hiring and Protiviti execution continue to improve and multiples re-rate toward mid-cycle levels.
- Intermediate target: $30.00 - reasonable mid-term (45 trading days) take-profit zone tied to mean reversion from deeply discounted levels.
Horizon commentary: I view this primarily as a long-term income + recovery trade. Expect the trade to play out over long term (180 trading days) to capture a multi-quarter recovery and multiple expansion. Use the mid-term horizon (45 trading days) to take partial profits at $30.00 if the stock rallies quickly, and re-evaluate the stop and remaining position sizing. For traders looking for a short-term (10 trading days) swing, the play is riskier: only consider small size and strict stops because staffing-sector news and short-volume-driven volatility can move the stock fast.
Technicals & market positioning
On a technical basis the stock is not overbought: RSI sits near 45.6 and the MACD shows bullish momentum. Short interest is elevated and short-volume has been high in recent sessions - a double-edged sword that can steepen rallies but also accelerate selloffs during negative headlines.
Risks and counterarguments
- Dividend sustainability concern. The annual dividend ($2.36) is greater than reported EPS ($1.31), giving a payout above 100% on an earnings basis. If free cash flow dries up, the board may be forced to cut or suspend the dividend.
- Cyclical hiring environment. Staffing and perm-placement volumes are sensitive to economic slowdowns. A renewed slowdown in corporate hiring would pressure revenues and margins.
- Valuation complacency. While FCF yield looks attractive, EV/EBITDA of 15.29 and P/E ~18 imply the market expects some normalization; multiple compression is possible if earnings miss or if Protiviti weakens.
- Institutional selling and sentiment. Recent exits by institutions (for example, a sizable sale reported in early April) show that some investors prefer moving into less-cyclical dividend names. Continued large selling could depress the stock further.
- Liquidity and volatility. Short interest and short-volume trends show elevated bearish bets; this increases two-way volatility and can generate rapid price moves both ways.
Counterargument: The high yield could be a classic value trap. If RHI's core staffing demand erodes further, earnings and cash flow could decline and the dividend may be unsustainable despite current FCF coverage. That scenario would result in a dividend cut and equity multiple contraction, leaving income investors exposed.
What would change my mind?
I would reduce conviction or move to neutral if: (1) free cash flow drops materially below the dividend run-rate for two consecutive quarters, (2) Protiviti revenues roll over meaningfully, or (3) management signals a dividend re-evaluation. Conversely, continued sequential revenue growth in talent solutions coupled with consistent Protiviti expansion would strengthen my bullish case and justify raising targets.
Conclusion
Robert Half is an income-first recovery trade: at $24.00 it yields nearly 10% and is backed by free cash flow that currently covers the dividend. The stock will remain cyclical and volatile, but early signs of sequential improvement and a diversified services mix make the risk-reward attractive for investors comfortable with the sector. Use the plan above (entry $24.00, stop $21.50, targets $30.00 intermediate and $40.00 primary) and size positions knowing the key risks around dividend sustainability and hiring trends.
Trade idea: Buy RHI at $24.00, stop $21.50, target $40.00 over ~180 trading days. Take partial profits near $30.00 on a faster move.